Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/11196347
Conclusion of this study
The present results show that anapsos (360 mg/day) improves cognitive performance, cerebral blood perfusion and brain bioelectrical activity in patients with senile dementia. These effects of anapsos were more marked in demented patients with mild mental deterioration and/or with dementia of the Alzheimer type.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study